Evidence has been presented that epigenetic termination of TNFAIP3 function by miR-125a and miR-125b could strengthen and prolong NF-κB activity, which promotes DLBCL lymphomagenesis [442]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.